GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » PB Ratio

KPC Pharmaceuticals (SHSE:600422) PB Ratio : 2.23 (As of Dec. 15, 2024)


View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), KPC Pharmaceuticals's share price is ¥16.29. KPC Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was ¥7.31. Hence, KPC Pharmaceuticals's PB Ratio of today is 2.23.

The historical rank and industry rank for KPC Pharmaceuticals's PB Ratio or its related term are showing as below:

SHSE:600422' s PB Ratio Range Over the Past 10 Years
Min: 1.23   Med: 2.16   Max: 8.79
Current: 2.23

During the past 13 years, KPC Pharmaceuticals's highest PB Ratio was 8.79. The lowest was 1.23. And the median was 2.16.

SHSE:600422's PB Ratio is ranked worse than
54.36% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs SHSE:600422: 2.23

During the past 12 months, KPC Pharmaceuticals's average Book Value Per Share Growth Rate was 5.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 6.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 9.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of KPC Pharmaceuticals was 41.10% per year. The lowest was -2.70% per year. And the median was 8.00% per year.

Back to Basics: PB Ratio


KPC Pharmaceuticals PB Ratio Historical Data

The historical data trend for KPC Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals PB Ratio Chart

KPC Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.95 1.47 1.75 2.15 2.98

KPC Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.77 2.98 3.01 2.51 2.17

Competitive Comparison of KPC Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, KPC Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KPC Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KPC Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where KPC Pharmaceuticals's PB Ratio falls into.



KPC Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

KPC Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=16.29/7.309
=2.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


KPC Pharmaceuticals  (SHSE:600422) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


KPC Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


KPC Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Executives
Qu Xiao Ru senior management
Xie Bo senior management
Meng Li senior management
Zhong Xiang Gang senior management
Wu Sheng Long senior management
Liu Jun Feng senior management
Wang Lei senior management
Zhang Meng Xun senior management
Hu Zhen Bo senior management
Sun Lei senior management
Xu Chao Neng senior management
Wang Jun senior management
Zhao Jian senior management
He Qin Director
Dai Xiao Chang senior management

KPC Pharmaceuticals Headlines

No Headlines